Advanced search
Publication Cover
OncoTargets and Therapy Volume 8, 2015 - Issue
Submit an article Journal homepage
89
Views
4
CrossRef citations to date
0
Altmetric
Original Research

NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway

Hong Wei1 Department of Ultrasonography, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
,
Hongbin Wang2 Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People’s Republic of China
,
Qiao Ji1 Department of Ultrasonography, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
,
Jiawei Sun1 Department of Ultrasonography, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
,
Lin Tao1 Department of Ultrasonography, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of China
&
Xianli Zhou1 Department of Ultrasonography, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of ChinaCorrespondence[email protected]
Pages 3721-3730 | Published online: 14 Dec 2015

References

  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin201161699021296855
  • MunagalaRAqilFGuptaRCPromising molecular targeted therapies in breast cancerInd J Pharmacol201143236245
  • EniuAIntegrating biological agents into systemic therapy of breast cancer: trastuzumab, lapatinib, bevacizumabJ BUON200712Suppl 1S119S12617935269
  • GreenMDFrancisPAGebskiVGefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerAnn Oncol2009201813181719553291
  • IshidaTKibaTTakedaMPhase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanesCancer Chemother Pharmacol20096436136919082596
  • WilsonCHCrombieCvan der WeydenLNuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formationEMBO J2012312486249722510880
  • KerrJSWilsonCHNuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinaseBiochem Soc Trans2013411055106023863178
  • BatlleEHendersonJTBeghtelHBeta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinBCell200211125126312408869
  • SansomOJReedKRHayesAJLoss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migrationGenes Dev2004181385139015198980
  • MadisonBBBraunsteinKKuizonEPortmanKQiaoXTGumucioDLEpithelial hedgehog signals pattern the intestinal cryptvillus axisDevelopment200513227928915590741
  • FinchAJSoucekLJunttilaMRSwigartLBEvanGIAcute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activationMol Cell Biol2009295306531519635809
  • TanEHSansomOJA new tumour suppressor enters the network of intestinal progenitor cell homeostasisEMBO J2012312444244522510881
  • AnastasJNMoonRTWNT signalling pathways as therapeutic targets in cancerNat Rev Cancer201313112623258168
  • LiuJPanSHsiehMHTargeting Wnt-driven cancer through the inhibition of porcupine by LGK974Proc Natl Acad Sci U S A2013110202242022924277854
  • RisbridgerGPDavisIDBirrellSNTilleyWDBreast and prostate cancer: more similar than differentNat Rev Cancer20101020521220147902
  • RuizCOeggerliMGermannMHigh NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growthProstate2012721678168722473923

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.